(Q39053369)

8 September 2017

title

Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects (English)

1 reference

8 September 2017

0 references

Hassan EO

1

1 reference

8 September 2017

el-Nahal N

series ordinal

2

1 reference

8 September 2017

el-Hussinie M

series ordinal

3

1 reference

8 September 2017

publication date

1 August 1999

1 reference

8 September 2017

1 reference

8 September 2017

volume

60

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

87-92

1 reference

A review of ‘once-a-month's combined injectable contraceptives

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900064-5

New once-a-month injectable contraceptives, with particular reference to Cyclofem/Cyclo-Provera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900064-5

A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900064-5

A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. II. The comparison of bleeding patterns. World Health Organization Task Force on Long-Acting Systemic Agents for Fer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900064-5

Life-table methods for contraceptive research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900064-5

A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900064-5

Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900064-5

Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900064-5

A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900064-5

10.1016/S0010-7824(99)00064-5

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference